Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men

Annals of Behavioral Medicine

Volumn 22, Issue 1, 2000, Pages 29-37

  Antoni, Michael H ^a   Cruess, Stacy ^b   Cruess, Dean G ^b   Kumar, Mahendra ^b   Lutgendorf, Susan ^b   Ironson, Gail ^b   Dettmer, Elizabeth ^b   Williams, Jessie ^b   Klimas, Nancy ^b   Fletcher, Mary Ann ^b   Schneiderman, Neil ^b  

^a University of Miami   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; CONTROLLED STUDY; DISTRESS SYNDROME; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; PSYCHOLOGICAL ASPECT; STRESS; TREATMENT OUTCOME; URINE LEVEL; VIRUS INFECTION;

EID: 18244430923     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02895165     Document Type: Article

References (74)

1. Clerici M, Trabattoni D, Piconi S, et al: A possible role for the cortisol/anticortisols imbalance in the progression of human immunodeficiency virus. Psychoneuroendocrinology. 1997, 22:S27-S31.
2. Biglino A, Limone P, Forno B, et al: Altered adrenocorticotropin and cortisol response to corticotropin-releasing hormone in HIV-1 infection. European Journal of Endocrinology. 1995, 133:173-179.
3. Christeff N, Gherbi N, Mammes O, et al: Serum cortisol and DHEA concentrations during HIV infection. Psychoneuroendocrinology. 1997, 22:S11-S18.
4. Kumar M, Kumar A, Morgan R, Szapocznik J, Eisdorfer C: Abnormal pituitary-adrenocortical response in early HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes. 1993, 6:61-65.
5. Lortholary O, Christeff N, Casassus P, et al: Hypothalamic-pituitary-adrenal function in human immunodeficiency virus-infected men. Journal of Clinical Endocrinology and Metabolism. 1996, 81:791-796.
6. Rondanelli M, Solerte S, Fioravanti M, et al: Circadian secretory pattern of growth hormone, insulin-like growth factor type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone, and prolactin during HIV infection. AIDS Research and Human Retroviruses. 1997, 13:1243-1249.
7. Cupps T, Fauci A: Corticosteroid-mediated immunoregulation in man. Immunology Review. 1982, 65:133-155.
8. Pavlidis N, Chirigos M: Stress-induced impairment of macrophage tumoricidal function. Psychosomatic Medicine. 1980, 42:47-54.
9. Herberman R, Holden H: Natural cell-mediated immunity. Advances in Cancer Research. 1978, 27:305-377.
10. Freedman L, Yoshinaga S, Vanderbilt J, Yamamoto K: In vitro transcription enhancement by purified derivatives of glucocorticoid receptor. Science. 1989, 245:298-301.
11. Norbiato G, Bevilacqua M, Vago T, Taddel A, Clerici M: Glucocorticoids and the immune function in the human immunodeficiency virus infection: A study in hypercortisolemic and cortisol-resistant patients. Journal of Clinical Endocrinology and Metabolism. 1997, 82:3260-3263.
12. Nair M, Schwartz S: Synergistic effect of cortisol and HIV-1 envelope peptide on the NK activities of normal lymphocytes. Brain, Behavior, and Immunity. 1995, 9:20-30.
13. Norbiato G, Bevilacqua M, Vago T: Glucocorticoids and the immune system in AIDS. Psychoneuroendocrinology. 1997, 22:S19-S25.
14. Lewin D: Protease inhibitors: HIV-1 summons a darwinion defense. Journal of NIH Research. 1996, 8:33-35.
15. Schneiderman N, Antoni MH, Ironson G: Cognitive-behavioral stress management and secondary prevention in HIV/AIDS. Psychology and AIDS Exchange. 1997, 22:1-8.
16. Hoffman MA: Counseling the seropositive client: A psychosocial model for assessment and intervention. The Counseling Psychologist. 1991, 19:467-542.
17. Rabkin J, Wagner G, Rabkin R: Treatment of depression in HIV+ men: Literature review and report of an ongoing study of testosterone replacement therapy. Annals of Behavioral Medicine. 1996, 18:24-29.
18. Gorman J, Kertzner R, Cooper T, et al: Glucocorticoid level and neuropsychiatric symptoms in homosexual men with HIV infection. American Journal of Psychiatry. 1991, 148:41-45.
19. Chrousos G: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New England Journal of Medicine. 1995, 332:1351-1362.
20. Jacobs S, Bruce M, Kim K: Adrenal function predicts demoralization after losses. Psychosomatics. 1997, 38:529-534.
21. Steiger A, Holsboer F: Nocturnal secretion of prolactin and cortisol in the sleep EEG in patients with major endogenous depression during an acute episode and after full remission. Psychiatry Research. 1997, 72:81-88.
22. Pearson B: Antiglucocorticoid therapies in major depression: A review. Psychoneuroendocrinology. 1997, 22:S125-S132.
23. Rao U, McCracken J, Lutchmansingh P, Edwards C, Ploand R: Electroencephalographic sleep and urinary free cortisol in adolescent depression: A preliminary report of changes from episode to recovery. Biological Psychiatry. 1997, 41:369-373.
24. Herbert T, Cohen S: Depression and immunity: A meta-analytic review. Psychological Bulletin. 1993, 113:472-486.
25. McEwen B: Protective and damaging effects of stress mediators. New England Journal of Medicine. 1998, 338:171-179.
26. Antoni MH, Schneiderman N, Fletcher M, et al: Psychoneuroimmunology and HIV-1. Journal of Consulting and Clinical Psychology. 1990, 58(1):38-49.
27. Schedlowski M, Jungk C, Schimanski G, Tewes U, Schmoll HJ: Effects of behavioral intervention on plasma cortisol and lymphocytes in breast cancer patients: An exploratory study. Psycho-Oncology. 1994, 3:181-187.
28. McGrady A, Woerner M, Bernal GAA, Higgins JT: Effect of biofeedback-assisted relaxation on blood pressure and cortisol levels in normotensives and hypertensives. Journal of Behavioral Medicine. 1987, 10:301-310.
29. McKinney C, Antoni M, Kumar M, Tims F, McCabe P: Effects of guided imagery and music (GIM) therapy on mood and cortisol in healthy adults. Health Psychology. 1997, 16:390-400.
30. Ironson G, Field T, Scafidi F, et al: Massage therapy is associated with enhancement of the immune system's cytotoxic capacity. International Journal of Neuroscience. 1996, 84:205-217.
31. Perna F, Antoni MH, Kumar M, Cruess D, Schneiderman N: Cognitive-behavioral intervention effects on mood and cortisol during exercise training. Annals of Behavioral Medicine. 1998, 20:92-98.
32. Antoni MH, Baggett L, Ironson G, et al: Cognitive-behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity. Journal of Consulting and Clinical Psychology. 1991, 59:906-915.
33. Esterling B, Antoni M, Schneiderman N, et al: Psychosocial modulation of antibody to Epstein-Barr viral capsid antigen and herpes virus type-6 in HIV-1 infected and at-risk gay men. Psychosomatic Medicine. 1992, 54:354-371.
34. Lutgendrof S, Antoni M, Ironson G, et al: Cognitive-behavioral stress management decreases dysphoric mood and Herpes Simplex Virus-Type 2 antibody titers in symptomatic HIV-seropositive gay men. Journal of Consulting and Clinical Psychology. 1997, 65:31-43.
35. Mulder CL, Emmelkamp P, Antoni MH, et al: Cognitive-behavioral and experiential group psychotherapy for HIV-infected homosexual men: A comparative study. Psychosomatic Medicine. 1994, 56:423-431.
36. Kelly J, Murphy D, Bahr R, et al: Outcome of cognitive-behavioral and support group brief therapies for depressed HIV-infected persons. American Journal of Psychiatry. 1993, 150:1679-1686.
37. Ironson G, Friedman A, Klimas N, et al: Distress, denial, and low adherence to behavioral intervention predict faster disease progression in gay men infected with HIV. International Journal of Behavioral Medicine. 1994, 1:90-105.
38. Mulder N, Antoni MH, Emmelkamp P, et al: Psychosocial group intervention and the rate of decline of immunologic parameters in asymptomatic HIV-infected homosexual men. Journal of Psychotherapy and Psychosomatics. 1995, 63:185-192.
39. Centers for Disease Control: Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR. Morbidity and Mortality Weekly Report. 1992, 41(RR-17):1-19.
40. Hamilton M: A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry. 1960, 23:56-62.
41. Williams J: Structured Interview Guide for Hamilton Depression Rating Scale, Archives of General Psychiatry. 1988, 45:742.
42. Spitzer R, Williams J, Gibbon M, First M: Structured Clinical Interview for DSM-III-R: Nonpatient Version for HIV Studies (SCID-NP-HIV 6/1/88). New York: Biometrics Research Department, New York Psychiatric Institute, 1988.
43. Spitzer R, Williams J, Gibbon M, First M: Structured Interview for DSM-III-R Personality Disorders (SCID-II). New York: New York State Psychiatric Institute, Biometrics Research, 1990.
44. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975, 12:189-198.
45. McNair D, Lorr M, Droppleman L: EITS Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service, 1981.
46. Kuhn C: Adrenocortical and gonadal steroids in behavioral cardiovascular medicine. In Schneiderman N, Kauffman P (eds), Handbook of Cardiovascular Methods. Plenum, 1989, 185-204.
47. Sellmeyer D, Grunfeld C: Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocrine Reviews. 1996, 17:518-532.
48. Byrnes D, Antoni M, Goodkin K, et al: Stressful events, pessimism, natural killer cell cytotoxicity and cytotoxic/suppressor T-cells in HIV+ Black women at risk for cervical cancer. Psychosomatic Medicine. 1998, 60:714-722.
49. Antoni MH, Schneiderman N, Ironson G: Stress management for HIV-infection. Unpublished manuscript, University of Miami, 1998.
50. Bernstein B, Borkovec T: Progressive Relaxation Training: A Manual for the Helping Professions. Champaign, IL: Research Press, 1973.
51. Luthe W: Autogenic Therapy. New York: Grune & Stratton, 1969.
52. Benson H, Klipper M: The Relaxation Response. New York: Avon. 1976.
53. Davis M, Eshelman E, McKay M: The Relaxation and Stress Reduction Workbook (3rd Ed.). Oakland, CA: New Harbinger, 1988.
54. Mason J: A Guide to Stress Reduction. Berkely, CA: Celestial Arts, 1986, 26-79.
55. Schneiderman N, Antoni MH, Ironson G, et al: HIV-1, immunity and behavior. In Glaser R (ed), Handbook of Human Stress and Immunity. New York: Academic, 1994.
56. Martin J: Psychological consequences of AIDS-related bereavement among gay men. Journal of Consulting and Clinical Psychology. 1988, 56:856-862.
57. Ader R, Felten D, Cohen N: Psychoneuroimmunology (2nd Ed.). New York: Academic Press, 1991.
58. Glaser R, Kiecolt-Glaser J: Handbook of Human Stress and Immunity. New York: Academic, 1994.
59. Leserman J, Petitto J, Perkins D, et al: Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. Archives of General Psychiatry. 1997, 54:279-285.
60. Patterson T, Shaw W, Semple S, et al: Relationship of psychosocial factors to HIV disease progression. Annals of Behavioral Medicine. 1996, 18:30-39.
61. Burack JH, Barren DC, Stall RD, et al: Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. Journal of the American Medical Association. 1993, 270:2567-2573.
62. Reed GM, Kemeny ME, Taylor SE, Wang HJ, Visscher B: Realistic acceptance as a predictor of decreased survival time in gay men with AIDS. Health Psychology. 1994, 13:299-307.
63. Antoni MH, Goldstein D, Ironson G, et al: Coping responses to HIV-1 serostatus notification predict concurrent and prospective immunologic status. Clinical Psychology and Psychotherapy. 1995, 2:234-248.
64. Lutgendorf S, Antoni MH, Ironson G, et al: Cognitive processing style, mood and immune function following HIV seropositivity notification. Cognitive Therapy and Research. 1997, 21:157-184.
65. Mulder C, de Vroome E, van Griensven G, Antoni MH, Sandfort T: Avoidance as a predictor of the biological course of HIV-1 infection over a 7-year period in gay men. Health Psychology. 1999, 18:107-113.
66. Rabkin JG, Williams JBW, Remien RH, et al: Depression, lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men. Archives of General Psychiatry. 1991, 48:111-119.
67. Turk D, Holzman A, Kerns R: Chronic pain. In Holroyd K, Creer T (eds), Self Management of Chronic Disease: Handbook of Clinical Interventions and Research. Orlando, FL: Academic Press, Inc. 1986.
68. Folkman S, Lazarus R, Gruen R, DeLongis A: Appraisal, coping, health status, and psychological symptoms. Journal of Personality and Social Psychology. 1986, 50(3):571-579.
69. Lutgendorf S, Antoni MH, Schneiderman N, Fletcher MA: Psychosocial counseling to improve quality of life in HIV-infected gay men. Patient Education and Counseling. 1994, 24:217-235.
70. Capitanio J, Lerche N: Social separation, housing relocation, and survival in Simiam AIDS: A retrospective analysis. Psychosomatic Medicine. 1998, 60:235-244.
71. Cruess D, Antoni MH, Kumar M, et al: Changes in symptoms of distress and sex hormones in symptomatic HIV+ gay men during a cognitive-behavioral stress management (CBSM) intervention. The Society of Behavioral Medicine. New Orleans, LA: March 1998.
72. Markham P, Salahuddin S, Veren K, Orndoff S, Gallo R: Hydrocortisone and some other hormones enhance the expression of HTLV-III. International Journal of Cancer. 1986, 37:67-72.
73. Sikkema K, Kelly J: Behavioral medicine interventions can improve the quality-of-life and health of persons with HIV disease. Annals of Behavioral Medicine. 1996, 18:40-48.
74. Frane JW: Some simple procedures for handling missing data in multivariate analysis. Psychometrika. 1976, 41:409-415.